Brightstar Associates LLC - 28 Feb 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc.

Role: 10%+ Owner
Signature: Brightstar Associates LLC, By: /s/ Timothy Fritzel, Member of the Board of Managers
Issuer symbol: N/A
Transactions as of: 28 Feb 2023
Net transactions value: +$24,277
Form type: 4
Filing time: 01 Mar 2023, 15:15:24 UTC
Previous filing: 24 Jan 2023
Next filing: 09 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DCPH	Common Stock	Exercise of in-the-money or at-the-money derivative security	$24,277	+2,427,693	+12%	$0.0100^*	22,145,707	28 Feb 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DCPH	Warrants (right to buy)	Exercise of in-the-money or at-the-money derivative security	$0	-2,427,693	-72%	$0.000000	962,137	28 Feb 2023	Common Stock	2,427,693	$0.0100	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The warrants have no expiration date.